Ciaramella Giuseppe's Insider Trades & SAST Disclosures
Ciaramella Giuseppe's most recent trade in Beam Therapeutics Inc was a trade of 70,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ciaramella Giuseppe.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2024 | 53,500 | 6,505 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Ciaramella Giuseppe | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 17 Dec 2024 | 53,500 | 162,650 (0%) | 0% | 0.7 | 35,845 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Sale of securities on an exchange or to another person at price $ 26.36 per share. | 06 Nov 2024 | 51,110 | 109,150 (0%) | 0% | 26.4 | 1,347,050 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Sale of securities on an exchange or to another person at price $ 26.27 per share. | 14 Oct 2024 | 51,110 | 160,260 (0%) | 0% | 26.3 | 1,342,752 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2024 | 27,318 | 0 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 14 Oct 2024 | 27,318 | 196,934 (0%) | 0% | 0.7 | 18,303 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2024 | 12,979 | 0 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.22 per share. | 14 Oct 2024 | 12,979 | 209,913 (0%) | 0% | 4.2 | 54,771 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Oct 2024 | 1,457 | 0 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.22 per share. | 14 Oct 2024 | 1,457 | 211,370 (0%) | 0% | 7.2 | 10,520 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 27,318 | 27,318 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 12,979 | 12,979 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Sale of securities on an exchange or to another person at price $ 32.12 per share. | 01 Apr 2024 | 4,534 | 169,616 (0%) | 0% | 32.1 | 145,632 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 35,000 | 174,150 (0%) | 0% | 0 | Common Stock | |
| Beam Therapeutics Inc | Ciaramella Giuseppe | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President and CSO | Sale of securities on an exchange or to another person at price $ 32.06 per share. | 21 Jul 2023 | 155,324 | 48,250 (0%) | 0% | 32.1 | 4,979,687 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.22 per share. | 21 Jul 2023 | 69,438 | 181,728 (0%) | 0% | 7.2 | 501,342 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2023 | 69,438 | 20,208 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.22 per share. | 21 Jul 2023 | 21,846 | 203,574 (0%) | 0% | 7.2 | 157,728 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2023 | 21,846 | 1,457 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jul 2023 | 1,206 | 19,002 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President and CSO | Sale of securities on an exchange or to another person at price $ 32.01 per share. | 21 Jul 2023 | 1,206 | 48,250 (0%) | 0% | 32.0 | 38,604 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President and CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.22 per share. | 21 Jul 2023 | 1,206 | 49,456 (0%) | 0% | 7.2 | 8,707 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 30.31 per share. | 03 Apr 2023 | 1,918 | 114,044 (0%) | 0% | 30.3 | 58,135 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 29.09 per share. | 03 Apr 2023 | 1,754 | 112,290 (0%) | 0% | 29.1 | 51,029 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 20,000 | 115,962 (0%) | 0% | 0 | Common Stock | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 40,297 | 150,905 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 03 Jan 2023 | 40,297 | 149,691 (0%) | 0% | 0.7 | 26,999 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 37.14 per share. | 03 Jan 2023 | 37,525 | 112,166 (0%) | 0% | 37.1 | 1,393,679 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 37.99 per share. | 03 Jan 2023 | 13,704 | 98,462 (0%) | 0% | 38.0 | 520,615 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 03 Jan 2023 | 9,106 | 105,068 (0%) | 0% | 0.7 | 6,101 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 9,106 | 0 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 4,326 | 0 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.22 per share. | 03 Jan 2023 | 4,326 | 109,394 (0%) | 0% | 4.2 | 18,256 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 39.07 per share. | 03 Jan 2023 | 1,900 | 96,562 (0%) | 0% | 39.1 | 74,233 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 39.94 per share. | 03 Jan 2023 | 600 | 95,962 (0%) | 0% | 39.9 | 23,964 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 30 Dec 2022 | 4,500 | 95,962 (0%) | 0% | 0.7 | 3,015 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Dec 2022 | 4,500 | 191,202 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 18,211 | 9,106 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 15,000 | 117,473 (0%) | 0% | 0 | Common Stock | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 59.11 per share. | 31 Mar 2022 | 1,859 | 115,614 (0%) | 0% | 59.1 | 109,885 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2021 | 39,700 | 207,702 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 29 Dec 2021 | 39,700 | 102,473 (0%) | 0% | 0.7 | 26,599 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2021 | 2,607 | 89,646 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.22 per share. | 22 Dec 2021 | 2,607 | 65,380 (0%) | 0% | 7.2 | 18,823 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 85.39 per share. | 22 Dec 2021 | 1,216 | 64,164 (0%) | 0% | 85.4 | 103,834 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 86.62 per share. | 22 Dec 2021 | 1,101 | 63,063 (0%) | 0% | 86.6 | 95,369 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 87.34 per share. | 22 Dec 2021 | 290 | 62,773 (0%) | 0% | 87.3 | 25,329 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 25,104 | 92,253 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.22 per share. | 20 Dec 2021 | 25,104 | 87,877 (0%) | 0% | 7.2 | 181,251 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 85.38 per share. | 20 Dec 2021 | 16,456 | 71,421 (0%) | 0% | 85.4 | 1,405,013 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 86.29 per share. | 20 Dec 2021 | 8,648 | 62,773 (0%) | 0% | 86.3 | 746,236 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.22 per share. | 20 Dec 2021 | 4,289 | 67,062 (0%) | 0% | 7.2 | 30,967 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 4,289 | 117,357 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 85.20 per share. | 20 Dec 2021 | 4,289 | 62,773 (0%) | 0% | 85.2 | 365,423 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2021 | 18,012 | 247,402 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 17 Sep 2021 | 18,012 | 62,773 (0%) | 0% | 0.7 | 12,068 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 28 Jun 2021 | 78,580 | 123,341 (0%) | 0% | 17 | 1,335,860 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 78,580 | 432,313 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 108.11 per share. | 28 Jun 2021 | 30,369 | 56,790 (0%) | 0% | 108.1 | 3,283,193 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 107.30 per share. | 28 Jun 2021 | 10,829 | 87,159 (0%) | 0% | 107.3 | 1,161,952 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 106.35 per share. | 28 Jun 2021 | 10,444 | 97,988 (0%) | 0% | 106.3 | 1,110,719 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 109.32 per share. | 28 Jun 2021 | 9,856 | 46,934 (0%) | 0% | 109.3 | 1,077,458 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 105.52 per share. | 28 Jun 2021 | 7,040 | 108,432 (0%) | 0% | 105.5 | 742,861 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 104.40 per share. | 28 Jun 2021 | 5,464 | 115,472 (0%) | 0% | 104.4 | 570,442 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 103.83 per share. | 28 Jun 2021 | 2,405 | 120,936 (0%) | 0% | 103.8 | 249,711 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 28 Jun 2021 | 2,173 | 44,761 (0%) | 0% | 110 | 239,030 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2021 | 25,000 | 44,761 (0%) | 0% | 0 | Common Stock | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 05 Mar 2021 | 4,030 | 19,761 (0%) | 0% | 0.7 | 2,700 | Common Stock |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 4,030 | 265,414 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2020 | 3,731 | 269,444 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Giuseppe Ciaramella | President & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.67 per share. | 30 Sep 2020 | 3,731 | 3,731 (0%) | 0% | 0.7 | 2,500 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges